期刊文献+

HPLC法测定氯法拉滨原料药中有关物质的含量 被引量:3

Content Determination of the Related Substances in Clofarabine Crude Drug by HPLC
原文传递
导出
摘要 目的:建立以高效液相色谱法测定氯法拉滨原料药中有关物质含量的方法。方法:色谱柱为Shim-pack VP-ODSC18,流动相为乙腈-乙酸铵溶液(10:90),流速为1.0mL.min-1,检测波长为262nm,进样量为20μL。对原料药进行专属性试验,以自身对照法测定3批原料药中有关物质的含量。结果:3批原料药在专属性试验中主峰与各杂质峰分离良好,有关物质含量分别为0.26%、0.26%、0.29%。结论:本方法简便、灵敏、重复性好,可用于氯法拉滨有关物质含量的测定。 OBJECTIVE: To establish an HPLC method for determination of the related substances in clofarabine crude drug. METHODS: The determination of sample was performed on Shim- pack VP- ODS C18 column with mobile phase consisted of acetonitrile -ammonium acetate solution (10 : 90) at a flow rate of 1.0 mL · min ^-1. The detection wavelength was set at 262 nm and the sample size was 20μL. A specificity test on the crude drug was performed, and the contents of the related substances in 3 batches of samples were determined by self - control method. RESULTS: The main peaks were distinctive from all the peaks of the foreign substances, and the contents of the related substances were 0.26%, 0.26% and 0.29%, respectively. CONCLUSION: This method is simple, sensitive and reproducible, and it is applicable for the determination of the related substances in the clofarabine crude drug.
出处 《中国药房》 CAS CSCD 北大核心 2009年第31期2461-2462,共2页 China Pharmacy
关键词 氯法拉滨 有关物质 高效液相色谱法 含量 Clofarabine Related substances HPLC Content
  • 相关文献

参考文献2

二级参考文献10

  • 1Gandhi V,Kantarjian H,Faderl S,et al.Pharmacokinetics and pharma-codynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias[].Clinical Cancer Research.2003 被引量:1
  • 2Kantarjian HM,Gandhi V,Kozuch P,et al.Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers[].Journal of Clinical Oncology.2003 被引量:1
  • 3McDonald LR,McCarthy CH.Nursing considerations for clofarabine in the treatment of acute lymphoblastic leukemia in children[].Clin J Oncol Nurs.2006 被引量:1
  • 4Gandhi V,Plunkett W.Clofarabine and nelarabine:two new purine nucleoside analogs[].Current Opinion in Oncology.2006 被引量:1
  • 5Jeha S,Kantarjian H.Clofarabine for the treatment of acute lymphoblastic leukemia[].Expert Review of Anticancer Therapy.2007 被引量:1
  • 6Curran MP,Perry CM.Clofarabine:in pediatric patients with acute lymphoblastic leukemia[].Paediatric Drugs.2005 被引量:1
  • 7Jeha S,Gandhi V,Chan KW,et al.Clofarabine,a novel nucleoside analog,is active in pediatric patients with advanced leukemia[].Blood.2004 被引量:1
  • 8Kline JP,Larson RA.Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia:a review[].Expert Opinion on Pharmacotherapy.2005 被引量:1
  • 9Faderl S,Gandhi V,Keating MJ,et al.The role of clofarabine in hematologic and solid malignancies development of a next-generation nucleoside analog[].Cancer.2005 被引量:1
  • 10Jeha S,Gaynon PS,Razzouk BI,et al.PhaseⅡstudy of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia[].Journal of Clinical Oncology.2006 被引量:1

共引文献10

同被引文献13

  • 1聂颖兰,傅得兴,胡欣,王唯红.新型抗白血病药氯法拉滨[J].中国新药杂志,2007,16(10):821-824. 被引量:9
  • 2Judith E, Rebecca M, Kumudha B, et aL A phase I clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias [J]. Clinical Trials and Observations, 2007,110(6 ) 1 762. 被引量:1
  • 3Hsieh Y, Christine J, Lee S, et al. Comparision of fast liquid chromatography]tandem mass spectrometric methods for simultaneous determination of cladribine and clofarabine in mouse plasma[J]. Journal of Pharmaceutical and Biomedical Analysis, 2007,44 (5) : 492. 被引量:1
  • 4Gandhi V, Kantarjian H, Faderl S, et al. Pharmacokinetics and pharmacodynamics of plasma clofarabine and cellular clofarabine triphosphate in patients with acute leukemias [J]. Clin Cancer Res, 2003,9 (17) : 6 335. 被引量:1
  • 5Lech-Maranda E, Korycka A, Robak T. Clofara- bine as a novel nucleoside analogue approved to treat patients with haematological malignancies: mechanism of action and clinical activity[J]. Mini Rev Med Chem,2009,9(7) -805-812. 被引量:1
  • 6Qian M, Wang X, Shanmuganathan K, et al. Pharmacokinetics of the anticancer agent 2-chloro-9 (2- deoxy-2fluoro-beta-D-arainofuranosyl ) adenine in rats[J]. Cancer Chemother Pharmacol, 1994, 33 (6):484-488. 被引量:1
  • 7Bonate PL, Arthaud L, Stuhler J, et al. The distribution, metabolism, and elimination of clofarabine in rats[J].Drug Metab Dispos,2005,33(6):739- 748. 被引量:1
  • 8王冠,刘明星,黄远郡.抗急性淋巴细胞白血病新药——氯法拉滨[J].中国新药与临床杂志,2008,27(7):538-542. 被引量:5
  • 9赵珺,陈祥峰.毛细管气相色谱法检测氯法拉滨中的残留溶剂[J].药学与临床研究,2008,16(4):330-332. 被引量:4
  • 10徐国京,祝莉霞,刘有伟.儿童急性淋巴细胞白血病新药——氯法拉滨[J].药学与临床研究,2009,17(2):131-134. 被引量:2

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部